| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 08:31 | Expecting Gilead To Break $70, Outperforming Merck | | - | Seeking Alpha |
| 11.02.
| Avanir Pharmaceuticals: The Perfect 2012 Stock For Cubs Fans | | - | Seeking Alpha |
| 11.02.
| Pfizer Recalls 1 Million Birth-Control Packs on Wrong Dosage | | - | Business Week |
| 11.02.
| Shares of BioMarin Pharmaceutical Rank the Highest in Terms of EBITDA Growth in the Biotechnology Industry | | - | SmarTrend |
| 11.02.
| Santarus is Among the Companies in the Pharmaceuticals Industry With the Highest EBITDA Growth | | - | SmarTrend |
| 11.02.
| Ukraine to produce diphtheria vaccine using Sanofi Pasteur technology | | 1 | Ukrinform |
| 11.02.
| Alexion Pharmaceuticals Shares Up 24.7% Since SmarTrend's Buy Recommendation | | 5 | SmarTrend |
| 11.02.
| 74.7% Return Seen to Date on SmarTrend Viropharma Call | | 2 | SmarTrend |
| 11.02.
| Uptrend Call Working As ISTA Pharmaceuticals Stock Rises 93.6% | | - | SmarTrend |
| 11.02.
| 51.7% Return Seen to Date on SmarTrend Maxygen Call | | - | SmarTrend |
| 10.02.
| Jury Rules Against Mylan In Sunovion Pharma Patent Litigation | | 165 | AFX News |
| CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced Friday that a jury has
rendered an unfavorable verdict in a patent infringement lawsuit filed by
Sunovion Pharmaceuticals Inc., f/k/a Sepracor...
Mehr lesen zu:
Jury Rules Against Mylan In Sunovion Pharma Patent Litigation | |
| 10.02.
| After Yesterday's Decline of 3.64%, Elite Pharmaceuticals Offers Investors Better Value | | 1 | SmarTrend |
| 10.02.
| LIGAND PHARMACEUTICALS INC - 10-Q/A, Quarterly Report | | - | SEC Filings |
| 10.02.
| Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex® Inhalation Solution | | 119 | PR Newswire |
| PITTSBURGH, Feb. 10, 2012 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL) today announced that a jury has rendered an unfavorable verdict in a patent infringement lawsuit filed by Sunovion...
Mehr lesen zu:
Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex® Inhalation Solution | |
| 10.02.
| Ligand Pharmaceuticals Set to Possibly Pullback After Yesterday's Rally of 1.59% | | - | SmarTrend |
| 10.02.
| Osiris Provides Update on Sanofi Deal | | 2 | Zacks |
| 10.02.
| Lowth, chief financial officer of AstraZeneca, sells £665,000 in shares | | 2 | This Is Money |
| 10.02.
| Incyte in Neutral Lane | | 1 | Zacks |
| 10.02.
| Alnylam to Webcast Presentations at Upcoming Investor Conferences | | 114 | Business Wire |
| Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi
therapeutics company, today announced that management will present a
company overview at the 14th Annual BIO...
Mehr lesen zu:
Alnylam to Webcast Presentations at Upcoming Investor Conferences | |
| 10.02.
| Pharmacyclics Shares Surged: What You Need to Know | | 1 | Motley Fool |
